Difgen Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 2 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.09 M
About Difgen Pharmaceuticals
Difgen Pharmaceuticals Private Limited (DPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 06 May 2022 (Two years and nine months 25 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹5.09 M.
Yatin Desai, Valiveti Brahmaji, Punit Thakrar, and Seven other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U72100TG2022PTC162383
- Company No.
162383
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 May 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Research & Development
Who are the key members and board of directors at Difgen Pharmaceuticals?
Board Members (10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Vasireddy  | Director | 04-Nov-2022 | Current |
Srinivasan Vedantham  | Director | 06-May-2022 | Current |
| Amol Walke | Director | 04-Jul-2022 | Current |
| Yatin Desai | Director | 24-May-2022 | Current |
| Valiveti Brahmaji | Additional Director | 21-Jan-2025 | Current |
| Punit Thakrar | Director | 04-Jul-2022 | Current |
Financial Performance of Difgen Pharmaceuticals.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Difgen Pharmaceuticals?
Unlock access to Difgen Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Venus Ethoxyethers Pvt LtdAmol Walke and Zubin Gandhi are mutual person
Riconpharma India Private LimitedValiveti Brahmaji is a mutual person
Polydrug Laboratories Private LimitedPunit Thakrar is a mutual person
Esteem Industries Private LimitedAmol Walke and Zubin Gandhi are mutual person
Indian Institute Of Cancer And Research Private LimitedValiveti Brahmaji is a mutual person
Dyna Glycols Private LimitedAmol Walke and Zubin Gandhi are mutual person
Charges (Loans)
Open Charges
₹0.51 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.51 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 May 2024 | Hdfc Bank Limited | ₹2.69 M | Open |
| 25 Jul 2022 | Hdfc Bank Limited | ₹2.41 M | Open |
How Many Employees Work at Difgen Pharmaceuticals?
Unlock and access historical data on people associated with Difgen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Difgen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Difgen Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
